Articles by Lim Jeong-yeo
Lim Jeong-yeo
-
Korean agencies to jointly tackle pediatric blood vessel crisis
Korean government agencies will work together in tackling artificial heart vessel supply issues in the wake of US company W.L. Gore’s withdrawal from the country in 2017, the Ministry of Food and Drug Safety said Sunday.The Drug Ministry, together with the Ministry of Welfare, estimates the issue will be resolved within this month, given that authorities will pay a visit to Gore establishments in the US for talks as early as this week.Artificial vessels, or “stretch” vascular grafts, by Gore had
Industry March 11, 2019
-
[Herald Interview] Unity goes beyond games to cars, AI, VR
Unity, a licensed game engine, is one of the most popularly used pieces of game developing software in the world. It’s the Adobe of games, if you will. For beginner developers, “Unity Personal” by Unity Technologies is a free-to-use version that anyone can use until their original content generates more than $100,000 yearly profit – at which point the developer is obliged to switch to the upper, paying model. Such is the “democratization of development” pursued by Unity Technologies ApS, the vid
Industry March 10, 2019
-
McDonald’s Korea encourages female staff on International Women’s Day
McDonald’s Korea invited female employees to its International Women’s Day event to recognize their contributions to the company, it said Friday.The event, held Wednesday, spotlighted some 20 female workers at McDonald’s across Korea, including mothers and daughters working together at the fast-food chain. The women were invited to the company’s headquarters in Jongno-gu, Seoul. Chief Executive Officer Cho Ju-yeon oversaw the occasion. (McDonald`s Korea)Cho said McDonald’s seeks to eliminate di
Industry March 8, 2019
-
Pharma firms go all-out in increasing R&D capacities
South Korean firms Daewoong Pharmaceutical and Celltrion Pharm are injecting funds to increase the capacity of their research and development facilities and production plants, despite some concerns that the hefty investments could weigh down their operations.Daewoong, the latest member to join the club of pharma firms with 1 trillion won ($887 million) annual sales, said that it would invest 70.5 billion won from May 31 this year to July 31, 2023, to build a connected collaboration and developme
Industry March 7, 2019
-
Essilor Korea calls for preemptive care for presbyopia
It is never too early to wear progressive lenses, Essilor Korea said at a press conference in Seoul marking the 60th anniversary of the French lens maker Essilor, Wednesady. Progressive lenses -- also known as multifocal or varifocal lenses -- are worn by people with presbyopia, a farsightedness often associated with old age.But in the digital age where the increased use of smartphones, tablets and computers are changing sight habits, it’s not only the old people who show signs of presbyopia, Es
Industry March 7, 2019
-
BTS: The faces behind Mediheal moisturizing masks
Global K-pop superstar group BTS will provide the new faces behind the Mediheal line of moisturizing masks from L&P Cosmetics. The South Korean skin care firm’s promotional videos featuring BTS hit social media at the start of March and are getting a heated response from fans. BTS will be Mediheal’s global ambassador for a year. L&P Cosmetics said it has collaborated with BTS since 2017, even before the singers signed on as its official models. The firm’s 3,000 special BTS packages, containing f
Industry March 5, 2019
-
Samsung Bioepis gains approval to sell bigger-size Ontruzant in Europe
Samsung Bioepis has gained approval to sell bigger-size Ontruzant in Europe, the company said Tuesday.Ontruzant is a biosimilar for breast cancer treatment referencing Swiss firm Roche’s blockbuster drug Herceptin.Available as a powder used to make up a solution for adding to an infusion into a vein, the 150 milligram version hit shelves in Europe in March 2018, after gaining European Medicine Agency’s approval in November 2017. The firm can now sell 420mg versions of the biosimilar. Samsung Bio
Industry March 5, 2019
-
ITC begins investigation of Medytox’s complaint against Daewoong
The US International Trade Commission has voted to institute an investigation of Daewoong’s Nabota, or Jeuveau outside of Korea, the USITC said in a news release Friday. It was earlier announced that Jeuveau, approved by the US Food and Drug Administration in January, was to be commercialized in the US by California-based firm Evolus in the second quarter of this year. However, the latest development raises questions on whether the plan will proceed. The investigation is based on a complaint
Industry March 4, 2019
-
[Feature] ‘Game addiction is real, but ...’
In early January, news spilled that Korean game company Nexon was up for sale, with China’s Tencent speculated as a potential buyer. Industrywide discussion ensued, with critics lambasting the government for eschewing support for the promising market, to the extent that even the biggest game company was setting to withdraw from management. Nexon is Korea’s biggest game company. Reports said its founder and largest shareholder, Nexon parent company NXC CEO Kim Jung-ju, was “tired of regulatory c
Industry March 4, 2019
-
Korean hypertension drugs gear up for bigger sales in 2019
Hypertension drugs gained unwanted attention last year: More than 170 generic drugs sold by 76 local drugmakers were recalled by the Drug Ministry for their inclusion of valsartan, a chemical substance that could raise the risk of cancer.However, the industry is looking for a rebound this year, with major Korean pharmaceutical firms pushing the envelope in the race for novel hypertension treatments. The biggest competitor is Boryung Pharmaceutical’s Kanarb, a new hypertension drug developed by a
Industry March 3, 2019
-
Ildong’s Aronamin best-selling OTC drug for 3rd year in row
Ildong Pharmaceutical’s multivitamin series Aronamin was the best-selling over the counter drug for the third consecutive year in 2018. OTC drugs can be purchased directly at medical stores without a doctor’s prescription.According to health care consulting firm IQVIA on Sunday, Aronamin marked 66.3 billion won ($58.8 million) sales last year, the highest among OTC drugs in Korea. Image captured from Ildong Pharmaceutical’s website The figure was a 2.3 percent drop from a year earlier, but enou
Industry March 3, 2019
-
Future Hyundai and Kia cars to have built-in video recording system
All future Hyundai and Kia automobiles will come with built-in video recording systems, more commonly called black boxes, the company announced Thursday, heralding changes in the business landscape for video recorder companies.Hyundai and Kia motors announced it would include drive video record systems for its future models, starting from the eighth generation Sonata to be released next month. The DVRS will be linked to the car’s audio-video-navigation screens and a smartphone.(Hyundai Motor)The
Industry Feb. 28, 2019
-
CJ CheilJedang mulling acquisition of US’ Prinova
CJ CheilJedang is reviewing the possible acquisition of US food additives company Prinova, though nothing is certain at this point, the company said Thursday.“We are aware that Prinova is open for bidding. However, we do not know who else is bidding for the deal nor how the seller wants to proceed,” said a CJ CheilJedang representative.(Yonhap)Prinova is one of many candidates CJ is considering acquiring, according to sources.Prinova is a global supplier to the food and nutrition industries. Ind
Industry Feb. 28, 2019
-
Korean pharma’s young scions rise in ranks
Younger members of the ownership families of domestic pharma firms are emerging in the public eye with wider involvement in management. Celltrion founder and Chairman Seo Jung-jin’s 32-year-old second son Seo Joon-serk is the latest such case. Seo will be promoted to director of the operation management department, effective Friday, according to the company. Seo joined the company in 2017. Celltrion said Seo will support and oversee the operations of biopharma production at plants. Seo’s older b
Industry Feb. 27, 2019
-
Nexon to start paying staff by the hour for overtime
South Korea’s biggest game company, Nexon, will scrap the practice of paying fixed overtime wages starting in August, the company announced Tuesday.Paying employees a fixed overtime wage is a widespread practice among game companies here, and has been blamed for causing game developers to work an excessive number of hours. “The most palpable difference is that we will now be paid for our overtime hours,” said Bae Soo-chan, the chief of Nexon’s labor union, called Starting Point. Negotiations bet
Industry Feb. 26, 2019
Most Popular
-
1
Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
-
2
Wealthy parents ditch Korean passports to get kids into international school
-
3
Man convicted after binge eating to avoid military service
-
4
First snow to fall in Seoul on Wednesday
-
5
Final push to forge UN treaty on plastic pollution set to begin in Busan
-
6
Korea to hold own memorial for forced labor victims, boycotting Japan’s
-
7
Nvidia CEO signals Samsung’s imminent shipment of AI chips
-
8
Industry experts predicts tough choices as NewJeans' ultimatum nears
-
9
Job creation lowest on record among under-30s
-
10
Opposition chief acquitted of instigating perjury